France· FR:69320675
FIBROVEIN 1 %, solution injectable
A medicinal product containing tétradécyl sulfate de sodium, registered in France by STD PHARMACEUTICAL (IRELAND) (IRLANDE).
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- TÉTRADÉCYL SULFATE DE SODIUM
- Manufacturer
- STD PHARMACEUTICAL (IRELAND) (IRLANDE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009268832565 ampoule(s) en verre de 2 ml
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tétradécyl sulfate de sodium in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomFibro-Vein 0.2% solution for injection 5ml vialsSTD Pharmaceutical Products Ltd
- CzechiaFIBROVEINSTD Pharmaceutical (Ireland) Limited, Dublin
- IrelandFibrovein 0.2% Solution for InjectionSTD Pharmaceutical (Ireland) Limited
- PolandFibroveinSTD Pharmaceutical (Ireland) Limited
- SpainVEINFIBRO 0,2 % SOLUCION INYECTABLEStd Pharmaceutical (Ireland) Limited
- CanadaTROMBOJECT 1%OMEGA LABORATORIES LIMITED
- NorwayFibroveinSTD Pharmaceutical Products
- GermanyFibroveinStd Pharmaceutical (Ireland) Ltd
Authorised across Europe · EMA
The same active substance is authorised in 6 EEA countries. Names it is sold under:
- Germany · Fibrovein
- Spain · Veinfibro
- Ireland · Fibrovein
- Italy · Fibrovein
- Poland · Fibrovein
- Romania · Fibrovein
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e7bfbe06-7d7a-4d86-b118-18ea41fec595 GET /v1/drugs/e7bfbe06-7d7a-4d86-b118-18ea41fec595?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "69320675",
"date_amm": "2013-12-13",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"substance": "TÉTRADÉCYL SULFATE DE SODIUM",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution injectable",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about tétradécyl sulfate de sodium.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.